A magnetic immunochromatographic test strip and method for rapid detection of MS-222
By spraying 3-aminobenzoic acid-BSA complete antigen and goat anti-mouse IgG on nitrocellulose membrane, combined with the competitive detection mode of superparamagnetic magnetic nanoprobes, the rapid and safety problems of the fishing anesthetic MS-222 detection were solved. , realize high sensitivity and low cost on-site inspection, making up for the shortcomings of the existing technology.
Patent Information
- Application Number
- CN202011471683.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2020-12-14
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2040-12-14
AI Technical Summary
The prior art cannot realize fast, low-cost and safe on-site detection of the fishing anesthetic MS-222, and there are problems such as complex, time-consuming and cumbersome pre-processing of samples.
Magnetic immunochromatography test strips were used, and MS-222 was performed by spraying 3-aminobenzoic acid-BSA complete antigen and goat anti-mouse IgG on the nitrocellulose membrane, combined with superparamagnetic magnetic nanoprobes, and using competition detection mode. Rapid quantitative inspection simplifies sample processing and reduces detection costs.
It realizes the rapid, high sensitivity and strong specificity of MS-222, which is easy to operate and is suitable for on-site large-scale inspection, reduces the safety risks to experimental personnel and meets the needs of rapid detection.
Smart Images

Figure CN112730857B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology and detection, and specifically relates to a preparation method and an application method of a magnetic immunochromatographic test strip suitable for low-cost rapid detection of MS-222 in aquatic products or water samples. Background Art
[0002] Anesthesia is a common method for transporting fresh aquatic products. Appropriate use of anesthetics can keep fresh aquatic products quiet, reduce metabolism, increase survival rate and transportation density, extend transportation time, reduce transportation losses, and reduce transportation costs. It is also easy to operate and manage. MS-222 (3-aminobenzoic acid ethyl ester methyl sulfonate), also known as tricaine and fish diazepam, is one of the common anesthetics used in fisheries. The United States, Canada, the European Union and other countries and regions allow the use of MS-222 in fresh aquatic products, but the requirements for its withdrawal period and maximum residue are different. Among them, the United States requires a withdrawal period of 21 days and a maximum residue of 1μg / mL for aquatic products treated with MS-222; Canada requires a withdrawal period of 5 days. Excessive intake of MS-222 can accumulate in the spleen and liver, damaging the physiological functions of the human body, causing adverse reactions such as allergies and hematopoietic disorders, and even causing carcinogenesis. In recent years, regulatory authorities and the media have revealed that some businesses, driven by profit, add excessive amounts of MS-222 to aquatic products and sell them without a withdrawal period. Anesthetic residues have become a major hidden danger to the quality and safety of fresh aquatic products. The use of fishery anesthetics in my country has a short history. At present, my country has not yet formally established laws and regulations on fishery anesthetics, lacks relevant testing standards and benchmark methods, and the supervision and management of anesthetics is still in a gray area. Rapid detection technology for anesthetics is also an area that needs to be developed urgently.
[0003] The current detection methods for MS-222 residues include liquid chromatography-tandem mass spectrometry (LC-MS / MS) and high performance liquid chromatography (HPLC). The quantitative detection limit of LC-MS / MS for residual MS-222 in aquatic products is 2μg / kg, and the recovery rate is 80% to 110%, which is relatively feasible; HPLC also has good reproducibility for detecting MS-222 in fish brains. Although these methods are highly sensitive and accurate, they are complex in sample pre-treatment, time-consuming, expensive, and require high operator requirements, making it difficult to meet the requirements of large-scale rapid detection on site.
[0004] Existing patent CN110747173A has developed a hybridoma cell line HOT that secretes tricaine monoclonal antibodies and its application, but the tri-n-butylamine used in the synthesis of the coated antigen belongs to a controlled highly toxic substance, which has potential safety hazards. CN108760947A proposes a GC-MS / MS detection method for seven anesthetics in aquatic products, but the sample pretreatment needs to be extracted with two organic solvents and solid phase extraction purification (samples are added to silica gel columns, n-hexane elution, drained, ethyl acetate elution, nitrogen blowing, acetonitrile constant volume, filter membrane), the operation is cumbersome, the sample processing time is greater than 80min, and it is impossible to achieve on-site rapid detection. CN107192767A proposes a method for isotope dilution gas chromatography-mass spectrometry to determine eugenol in aquatic products, and its sample pretreatment includes organic solvent extraction, n-hexane defatting, rotary evaporation, C18 solid phase extraction column purification, nitrogen blowing, filter membrane and other processes, which also has the problems of complex operation, long time consumption, and professional equipment, and is not suitable for on-site rapid detection. CN110987922B discloses a method for detecting eugenol anesthetics in aquatic products, which requires organic solvent extraction, pH adjustment, olefin double bond structure detection, carbamate structure detection and other steps, involves spectrophotometer, centrifuge and nitrogen blow-through instrument processing, the detection time is greater than 1.25h, and the purpose of on-site rapid detection cannot be achieved, and the method lacks detection performance analysis. CN110746286A discloses a method for preparing eugenol hapten and complete antigen and its application in kits and test strips, the detection method requires the use of professional equipment such as microplate reader, vortex oscillator, centrifuge, shaker, nitrogen blow-through instrument, the pre-treatment time is greater than 70min, the detection time is greater than 85min, and the purpose of on-site rapid detection cannot be achieved either. CN107189988B discloses a hybridoma cell line CS12 secreting anti-eugenol monoclonal antibodies and its application. Eugenol added to fish meat is detected by enzyme-linked immunosorbent assay (ELISA). The pretreatment includes organic solvent extraction, vortex oscillation, centrifugation, nitrogen blowing and other steps, and there is also a problem of cumbersome processing. CN110938011A discloses a preparation and application method of benzocaine hapten, complete antigen and antibody, but the enzyme-linked immunosorbent assay requires instruments and equipment such as microplate readers, and it is also impossible to perform rapid detection on site. In summary, the current detection of fishery anesthetics has the following problems: the synthesis of 3-aminobenzoic acid-BSA complete antigen requires highly toxic reagents; sample pretreatment requires solid phase extraction, nitrogen blowing and centrifugation, and even rotary evaporation, which is cumbersome and time-consuming; ELISA and chemical detection experiments also have similar problems. Summary of the invention
[0005] The present invention aims to provide a method for rapidly detecting the fishery anesthetic MS-222, a magnetic immunochromatographic test strip and a kit.
[0006] The technical solution is: a magnetic immunochromatographic test strip for rapid detection of MS-222, characterized in that it comprises a bottom plate and a sample pad, a binding pad, a nitrocellulose membrane (NC membrane) and a water absorbent pad sequentially attached to the bottom plate; a detection line (T line) and a quality control line (C line) are provided on the nitrocellulose membrane; the detection line is coated with 3-aminobenzoic acid-carrier protein complete antigen, and the quality control line is coated with sheep anti-mouse IgG.
[0007] 3-aminobenzoic acid-BSA complete antigen refers to a conjugate synthesized with 3-aminobenzoic acid as hapten and BSA or OVA as carrier protein. The preparation process of the conjugate includes the following steps:
[0008] 1) Activation: 3-aminobenzoic acid is dissolved in N,N-dimethylaniline or N,N-dimethylformamide to a concentration of 10-60 mg / mL, 2%-5% by volume of triethylamine is added, and the mixture is reacted at 2-8°C for 10-20 min, followed by addition of 0.5%-1% by volume of isobutyl chloroformate, and the mixture is reacted at 2-8°C for 1-3 h; or,
[0009] 3-aminobenzoic acid is dissolved in N,N-dimethylaniline or N,N-dimethylformamide, and 1-ethyl-3-dimethylaminopropylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) are added in a mass ratio of 2:1-2, and the amount ratio of 3-aminobenzoic acid to 1-ethyl-3-dimethylaminopropylcarbodiimide hydrochloride is 1:1-2; the concentration of 3-aminobenzoic acid in the reaction system is 10-60 mg / mL;
[0010] 2) Coupling: Add BSA or OVA to the above solution and react for 8-12 hours. The mass ratio of BSA or OVA to 3-aminobenzoic acid is 1:1.5-2; preferably BSA;
[0011] 3) Purification: The above conjugate is placed in a 20-40 kD dialysis bag and dialyzed with a phosphate buffer having a pH of 7.0-7.4; the dialysis time is 36-96 h, preferably 48-72 h; preferably, the pH of the phosphate buffer is 7.4.
[0012] In a preferred embodiment of the present invention, in step (1), the concentration of 3-aminobenzoic acid solution is 30 mg / mL, the amount of triethylamine is 3% by volume, and the amount of isobutyl chloroformate is 1% by volume; or in step (1), the mass ratio of 1-ethyl-3-dimethylaminopropylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) is 2: 1. In step (3), dialysis is performed for 72 hours using a phosphate buffer having a pH of 7.4 and a concentration of 10 mmol / L.
[0013] The preparation method of the test strip comprises the following steps:
[0014] (a) Nitrocellulose membrane coating: Use a membrane scribing instrument to spray 3-aminobenzoic acid-BSA complete antigen and goat anti-mouse IgG on the corresponding area of the nitrocellulose membrane as the test line (T line) and the quality control line (C line). The distance between the test line and the quality control line is 1-10 mm. Place in an oven at 37°C and dry for 1-6 h.
[0015] (b) Assembling the test strip: Assemble the sample pad, conjugate pad, nitrocellulose membrane, absorbent pad and PVC base plate in sequence. To ensure smooth flow of the sample, there should be a certain overlap when assembling the test strip, with an overlap of 1.0-3.0 mm. Then cut into 2-8 mm wide test strips and seal them for dry storage.
[0016] A method for rapid detection of MS-222, comprising the steps of:
[0017] (1) mixing the sample to be tested with the magnetic nanoprobe and reacting for 1-30 minutes; the magnetic nanoprobe is a superparamagnetic nanoparticle coupled with the MS-222 monoclonal antibody; preferably, the superparamagnetic nanoparticle is covalently linked to the MS-222 monoclonal antibody using 1-ethyl-3-dimethylaminopropylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS);
[0018] (2) adding a chromatography solution and mixing thoroughly for 5-60 seconds, and then dripping it onto the sample pad of the magnetic immunochromatographic test strip; preferably, the chromatography solution is a PBS buffer solution containing 5%-20% BSA by mass and 1%-5% Tween-20 by volume, with a pH of 7.0-8.0;
[0019] Preferably, the particle size of the superparamagnetic nanoparticles is 100-300 nm. Preferably, the superparamagnetic nanoparticles are superparamagnetic nano Fe3O4 particles;
[0020] (3) Qualitative or quantitative judgment results.
[0021] Step (3) includes two methods: qualitative observation by naked eyes and quantitative determination by instruments.
[0022] The result judgment in step (3) includes the following two methods:
[0023] 1) Qualitative judgment: Observe the color of T line and C line by naked eyes for qualitative judgment. Compare the color depth of sample and negative control test line to determine the positive and negative results. If the color of sample test line is close to or darker than negative control, it is a negative result. If the color of test line is lighter than negative control or no color is shown, it is a positive result.
[0024] 2) Quantitative determination: Use a magnetic immunochromatographic analyzer to measure the signal values on the T and C lines for quantitative detection. Establish a standard curve based on the T / C ratio B / B0 between the sample and the negative control, and calculate the content of MS-222 in the sample.
[0025] The method for preparing the magnetic nanoprobe in step (2) comprises the following steps:
[0026] A) washing the superparamagnetic nanoparticles with an activation buffer (MEST, 10 mM morpholineethanesulfonic acid buffer containing 0.01-0.05% Tween-20, pH=5.0);
[0027] B) Add EDC and NHS in a mass ratio of 1:1-2 into the centrifuge tube containing the magnetic beads, and vertically rotate to mix for 10-60 minutes; the ratio of EDC to superparamagnetic nanoparticles is 0.01-0.1:1;
[0028] C) Add MS-222 monoclonal antibody, shake thoroughly, and vertically rotate to mix for 1-5 hours; the ratio of MS-222 monoclonal antibody to superparamagnetic nanoparticles is 0.005-0.1:1.
[0029] D) using BSA to block the unreacted groups on the surface of the magnetic nanoprobe. Preferably, 0.5%-5% BSA is used as a blocking agent to block the unreacted groups on the surface of the magnetic nanoprobe for 1 to 8 hours.
[0030] Afterwards, the magnetic nanoprobe is stored in a preservation solution (BST buffer solution containing 0.1-1% sodium azide and 0.1-1% BSA) for future use.
[0031] The chromatography solution in step (2) is a PBS buffer solution containing 5%-20% BSA by mass and 1%-5% Tween-20 by volume, with a pH of 7.0-8.0. Preferably, the pH of the PBS buffer solution is 7.0-7.4.
[0032] When used to detect MS-222 in aquatic products, the sample pretreatment method is as follows: after mixing the aquatic product to be tested with deionized water, add acetonitrile for extraction, take the supernatant and remove moisture with salt, let it stand to dry the acetonitrile, and then add phosphate saline (PBS) buffer to re-dissolve it.
[0033] The salts are magnesium sulfate and sodium chloride. Preferably, the pH of the PBS buffer is 7.0-7.4.
[0034] The present invention combines superparamagnetic magnetic beads and immunochromatographic test strip technology, and adopts a competitive detection mode to perform rapid quantitative detection of MS-222 in aquatic products. The detection principle of the test strip is as follows:
[0035] After the sample to be tested is mixed and incubated with the magnetic nanoprobe, it is dropped onto the sample pad for detection. If the sample to be tested does not contain MS-222, the magnetic nanoprobe directly binds to the 3-aminobenzoic acid-BSA complete antigen on the T line and aggregates, and the T line is clearly colored; if the sample to be tested contains MS-222, the magnetic nanoprobe competes with the T line antigen to bind to the magnetic nanoprobe, and the color of the T line is weakened. The higher the MS-222 content, the lighter the color of the T line. For positive results, only the C line has a band, the T line of a weakly positive result has a faint color, and both the C and T lines of a negative result have obvious bands.
[0036] The present invention combines superparamagnetic magnetic beads and immunochromatographic test strip technology and adopts a competitive detection mode to perform rapid quantitative detection of MS-222 in aquatic products.
[0037] The present invention solves the above problems and provides a rapid quantitative detection method for MS-222 in aquatic products. The present invention combines magnetic nanoprobes with immunochromatographic test strip technology, prepares immunochromatographic test strips by spraying 3-aminobenzoic acid-BSA complete antigen and goat anti-mouse IgG on the detection line (T line) and quality control line (C line) of NC membrane, and uses a magnetic signal analyzer for detection, thereby achieving higher sensitivity detection and establishing a rapid quantitative detection method for test strips of fishery anesthetic MS-222. The test strip method has strong specificity, high sensitivity, simple operation, and low cost, which well compensates for the shortcomings of existing large-scale instrument analysis methods and meets the needs of on-site rapid detection.
[0038] The beneficial effects achieved by the present invention compared with the prior art are:
[0039] (1) The test strip product of the present invention is small in size, light in weight, convenient to carry and store, simple in operation, and can be completed by ordinary personnel. The result interpretation only takes 15 to 20 minutes, and can realize on-site rapid qualitative and quantitative detection of large quantities of samples, and is easy to promote and use;
[0040] (2) It has high sensitivity, strong specificity, simple operation and low cost, which can make up for the shortcomings of existing large-scale instrument analysis methods and meet the needs of rapid on-site detection;
[0041] (3) The present invention uses triethylamine instead of the highly toxic controlled chemical tri-n-butylamine in patent CN110747173A to synthesize the complete antigen, and the raw materials are easier to obtain, thereby reducing safety risks and toxic effects on experimenters; and by improving the solvent used in the synthesis of 3-aminobenzoic acid-BSA complete antigen and the method of coupling the hapten with the carrier protein, the complete antigen that improves the detection performance of the test strip is screened out. BRIEF DESCRIPTION OF THE DRAWINGS
[0042] Figure 1 This is the test principle diagram of the MS-222 rapid test strip of the present invention
[0043] Figure 2 It is the sensitivity test result of the test strip of the present invention.
[0044] Figure 3 It is the quantitative curve of the sensitivity result of the test strip of the present invention.
[0045] Figure 4 It is the specific detection result of the test strip of the present invention.
[0046] Figure 5 It is a specific quantitative diagram of the test strip of the present invention. DETAILED DESCRIPTION
[0047] Any feature disclosed in this specification (including any additional claims and abstract), unless otherwise stated, may be replaced by other alternative features that are equivalent or have similar purposes. That is, unless otherwise stated, each feature is only an example of a series of equivalent or similar features.
[0048] Example 1 Synthesis of 3-aminobenzoic acid-BSA complete antigen
[0049] This embodiment provides a method for synthesizing a 3-aminobenzoic acid-BSA complete antigen, comprising the following steps:
[0050] 3-Aminobenzoic acid was dissolved in N,N-dimethylformamide at a concentration of 30 mg / mL. 3% volume triethylamine was added to the solution, and after reacting for 10 min, 1% volume isobutyl chloroformate was added. After reacting for 1 h, 0.3 mL was added to BSA solution (BSA 5.0 mg) to make up the volume to 2 mL, and the reaction was allowed to proceed overnight. The obtained conjugate was dialyzed with pH = 7.4, 10 mmol / L phosphate buffer for 72 h and stored at –20 °C for future use.
[0051] Example 2 Preparation of test strips
[0052] (1) Nitrocellulose membrane coating: Use a membrane scribing instrument to spray 3-aminobenzoic acid-BSA complete antigen and goat anti-mouse IgG on the corresponding area of the nitrocellulose membrane as the test line (T line) and the quality control line (C line). The distance between the test line and the quality control line is 1-10 mm. Place in an oven at 37°C and dry for 1-6 h.
[0053] (2) Assembly of the test strip: Assemble the sample pad, conjugate pad, nitrocellulose membrane, absorbent pad and PVC base plate in sequence. To ensure smooth flow of the sample, there should be a certain overlap when assembling the test strip, with an overlap of 1.0-3.0 mm. Then cut into 2-8 mm wide test strips, seal and dry for storage.
[0054] Example 3 Construction of magnetic nanoprobe
[0055] The construction of the magnetic nanoprobe includes the following steps:
[0056] 1 mg of superparamagnetic Fe3O4 nanoparticles (about 200 nm in diameter) were washed twice with 10 mM morpholineethanesulfonic acid buffer containing 0.01% Tween-20, and then 10 mg of EDC and 20 mg of NHS were added. After reacting at 25°C for 20 min, an appropriate amount of MS-222 monoclonal antibody was added for 2 h, and finally 2% BSA was added for overnight reaction for blocking. The prepared magnetic nanoprobe was stored in a 1% BSA BST buffer solution at a concentration of 80 μg / mL.
[0057] Example 4 MS-222 test strip detection
[0058] Take 5 μL of the magnetic nanoprobe of Example 3 and mix it with 100 μL of the sample. After reacting at 25°C for 5 minutes, add 20 μL of chromatography solution (PBS solution containing 3% Tween-20, 30% BSA, pH=7.4), mix well and drop it onto the sample pad of the test strip. Qualitatively observe the color development of the C line and T line by naked eyes. Use a magnetic immunochromatographic analyzer to quantitatively detect the signal values of the T and C lines of the test strip. The principle is as follows Figure 1 A and Figure 1 B.
[0059] Example 5 Sensitivity of MS-222 Immunochromatographic Test Strip
[0060] The MS-222 rapid test strip prepared by the present invention was subjected to a sensitivity test:
[0061] The test strips were tested using 0-10 μg / mL series of MS-222 solutions. The MS-222 concentration at which the T line disappears was used as the qualitative detection limit of the test strips. The qualitative test results are shown in Figure 2 As can be seen from the figure, the color of the T line gradually becomes lighter with the increase of MS-222 concentration. The color of the T line of 5.0μg / mL MS-222 is invisible to the naked eye, so the qualitative sensitivity of the test strip is 5.0μg / mL.
[0062] The B / B0 value was calculated based on the magnetic signal values of the T and C lines of the test strip, and the MS-222 standard curve was drawn. After calculation, the quantitative sensitivity of the test strip for PBS-diluted MS-222 was 0.13 μg / mL, which is far lower than the US requirement for the maximum residual amount of MS-222 in aquatic products (1 μg / mL).
[0063] Example 6 Detection of MS-222 in water samples
[0064] The MS-222 rapid test strip prepared by the present invention is used to detect MS-222 in water samples:
[0065] The MS-222 standard was diluted to 1.0, 2.5, and 5.0 μg / mL using aquaculture water to prepare MS-222 artificially contaminated water samples, which were filtered through a 0.22 μm membrane and tested using HPLC and MS-222 test strips. The results are shown in Table 1. The CV values of HPLC and the test strip method within the detection range were both less than 7.0%, and the test results of the two methods were in good consistency.
[0066] Table 1: Detection results of MS-222 in water samples
[0067]
[0068] Example 7 Detection of MS-222 in fish
[0069] The MS-222 rapid detection test strip prepared by the present invention is used to detect MS-222 in fish samples.
[0070] The sample pretreatment method suitable for MS-222 test strip detection includes the following steps:
[0071] 0.5, 1.25, 2.5 μg MS-222 were added to 0.5 mL deionized water, and then mixed with 1 g minced fish meat, and extracted with the QuEChERS kit: 1 mL acetonitrile was added and mixed for 5 min, and then 0.5 g anhydrous magnesium sulfate and 0.3 g sodium chloride were added to react for 2 min, and the supernatant was collected after centrifugation for 5 min. After the acetonitrile was dried, it was re-dissolved with 0.5 mL PBS buffer with pH = 7.4 and a concentration of 10 mmol / L, and the spiked concentrations were 1.0, 2.5, and 5.0 μg / mL, respectively, and detected using the MS-222 test strips and HPLC method of Example 2.
[0072] The test results are shown in Table 2. The test strip test results are in good agreement with the HPLC results.
[0073] Table 2: Detection results of MS-222 in fish
[0074]
[0075] Example 8 Specificity of MS-222 Immunochromatographic Test Strip
[0076] The MS-222 rapid test strip prepared by the present invention is subjected to a specificity test:
[0077] MS-222 and different fishery anesthetics such as bupivacaine hydrochloride, benzocaine, lidocaine, and eugenol were diluted to 10 μg / mL with PBS buffer and tested with test strips. The specificity of the test strips was analyzed based on the color development. The results are shown in Figure 4Except for the positive result of MS-222, the others were negative. Figure 5 , the MS-222 B / B0 ratio is less than 0.2, indicating a strong positive result; the other anesthetic B / B0 ratios are close to 1.0, all of which are negative results, indicating that the test strip can ensure that there is no interference from other anesthetics when detecting MS-222. MS-222 and benzocaine are isomers of each other, and this test strip has no cross reaction to benzocaine, further indicating that the test strip has good specificity.
Claims
1. A method for rapid detection of MS-222, characterized in that: The following steps are involved: (1) Mixing the sample to be tested with the magnetic nanoprobe and reacting for 1-30 minutes; the magnetic nanoprobe is a superparamagnetic nanoparticle coupled with MS-222 monoclonal antibody; (2) Add the chromatography solution and mix thoroughly for 5-60 seconds, then drop it onto the sample pad of the magnetic immunochromatographic test strip; The magnetic immunochromatographic test strip comprises a bottom plate and a sample pad, a binding pad, a nitrocellulose membrane and a water-absorbing pad sequentially attached to the bottom plate; The nitrocellulose membrane is provided with a detection line and a quality control line; the detection line is coated with 3-aminobenzoic acid-carrier protein complete antigen, and the quality control line is coated with goat anti-mouse IgG; The 3-aminobenzoic acid-carrier protein complete antigen refers to a conjugate synthesized with 3-aminobenzoic acid as a hapten and BSA or OVA as a carrier protein; 3-aminobenzoic acid and the carrier protein are coupled using 1-ethyl-3-dimethylaminopropylcarbodiimide hydrochloride and N-hydroxysuccinimide, or 3-aminobenzoic acid and the carrier protein are coupled using triethylamine and isobutyl chloroformate; (3) Qualitative or quantitative judgment results.
2. The method according to claim 1, characterized in that The method for preparing the magnetic nanoprobe described in step (1) is to covalently link superparamagnetic nanoparticles to MS-222 monoclonal antibody using 1-ethyl-3-dimethylaminopropylcarbodiimide hydrochloride and N-hydroxysuccinimide.
3. The method according to claim 2, characterized in that The particle size of the superparamagnetic nanoparticles is 100-300 nm.
4. The method according to claim 1, characterized in that: The chromatography solution in step (2) is a PBS buffer solution containing 5%-20% BSA by mass and 1%-5% Tween-20 by volume, with a pH of 7.0-8.
0.
5. The method according to claim 4, characterized in that The qualitative judgment method of step (3) is: compare the color depth of the sample and negative control test lines to determine the positive and negative results. If the color of the sample test line is close to or darker than the negative control, it is a negative result; if the color of the test line is lighter than the negative control or no color is shown, it is a positive result; The quantitative determination method of step (3) is instrumental quantitative determination. A magnetic signal analyzer is used to determine the content of magnetic beads bound to the test line and the quality control line, and the ratio T / C between the two is calculated. A standard curve is established based on the ratio B / B0 of T / C between the sample and the negative control, thereby calculating the content of MS-222 in the sample.
6. The method according to claim 1, characterized in that The method for preparing the magnetic nanoprobe in step (2) comprises the following steps: A) Take the superparamagnetic nanoparticles and wash them with activation buffer; B) Add EDC and NHS in a mass ratio of 1:1-2 into the centrifuge tube containing magnetic beads, and vertically rotate to mix for 10-60 minutes; the ratio of EDC to superparamagnetic nanoparticles is 0.01-0.1:1; C) Add MS-222 monoclonal antibody, shake thoroughly, and rotate vertically to mix for 1-5 h; the ratio of MS-222 monoclonal antibody to superparamagnetic nanoparticles is 0.005-0.1:1; D) The unreacted groups on the surface of the magnetic nanoprobe are blocked with BSA.
7. The method according to claim 1, characterized in that The preparation method of the 3-aminobenzoic acid-carrier protein complete antigen comprises the following steps: 1) Activation: Dissolve 3-aminobenzoic acid in N,N-dimethylaniline or N,N-dimethylformamide to a concentration of 10-60 mg / mL, add 2%-5% by volume of triethylamine, react at 2-8°C for 10-20 min, then add 0.5%-1% by volume of isobutyl chloroformate and react at low temperature for 1-3 h; or, 3-aminobenzoic acid is dissolved in N,N-dimethylaniline or N,N-dimethylformamide, and 1-ethyl-3-dimethylaminopropylcarbodiimide hydrochloride and N-hydroxysuccinimide are added in a mass ratio of 1:1-2, and the amount ratio of 3-aminobenzoic acid to 1-ethyl-3-dimethylaminopropylcarbodiimide hydrochloride is 1:1-2; the concentration of 3-aminobenzoic acid in the reaction system is 10-60 mg / mL; 2) Coupling: Add BSA or OVA to the above solution and react overnight for 8-12 h. The mass ratio of BSA or OVA to 3-aminobenzoic acid is 1:1.5-2. 3) Purification: Place the above conjugate in a 20-40 kD dialysis bag and dialyze it against phosphate buffer at pH = 7.0-7.4.
